Chander Shekhar Sibal, EVP, Fujifilm India
At Fujifilm, we are continuously innovating, creating new technologies, products and services, and depending on the market demand where we will introduce our new products. We always try to go an extra mile to meet our customers' needs and provide best in class services. With these initiatives, our aim is to strengthen our presence in the Indian medical diagnostic space.
DR and FFDM markets are growing at a fast pace, approximately at 20 percent-plus. We will launch new products in digital radiography and flat panel detector, which would definitely reduce the X-ray dose and enhance the image quality. Also, there are plans to launch Synapse 5.0 PACS with faster archiving time while utilizing 50 percent less bandwidth. We are expecting to grow by more than 15 percent in terms of revenue since last year.
We have installed a total of 14 Amulet Innovality till date and are planning to install six to eight more in the current fiscal year. Globally, we have over 2500 installations for the Amulet Innovality. Our machines help in early diagnosis as we are able to detect 50 micron resolution which is best in the industry and our dose is less than 1 mgy, so it gives highest image quality at lower dose.
Living up to our motto, which is Value from Innovation, we are committed to provide products and services that not only enhance image quality and work flow but also keep the patient's well-being in mind by delivering the least X-ray dose to patients undergoing the procedure. We are installing CR in every nook and corner of the country and this digitized X-ray means converting analog X-ray to digital. We have DR panel and full room DR mobile DR for direct digital radiography. The equipment improves workflow and brings down dosage to a very low level.
Fujifilm Synapse is a one-stop shop. With an integrated mammography, RIS, and PACS solution, high-end FDA-approved 3-D post processing applications cater to entire hospital's departments right from radiology, cardiology, surgery, orthopedics, neurology, urology, dental and maxillofacial, podiatry, and forensic science for virtual autopsies. Oracle database embedded in PACS helps better management of patient records. We have recently introduced Synapse VNA (Vendor Neutral Archive) for DICOM and non-DICOM modalities in hospitals so that patient's record is stored and archived in a seamless manner. This can also help in research and development of new procedures and data analysis of disease. We also specialize in point-of-care ultrasound.
We have recently joined hands with PPP customer KRSNA Diagnostic for supplying 1000 CRs for their India-wide requirements. We have supplied over 100 CRs to the Andhra Pradesh government for digitizing their hospitals and medical colleges. We have also received orders from the Government of Turkey for their mammography program and have supplied 100 FFDM for that purpose. Also, we have installed FFDM at medical colleges like IGMC Shimla, Sri Ramachandra University, Chennai, Aurangabad Medical College, Tata Memorial Hospital, Mumbai, Mahajan Imaging Delhi, and NM Medical Hospital, Mumbai, for early detection of breast cancer.
We have created a promising future for ourselves in the Indian market. Each category that Fujifilm has its presence in is driven by long-term commitment toward our customers and partners. Our growth drivers are coming from new-age customers who are well aware of what they want and are quality conscious.
We have made an effort to investigate the Indian market and have realized that Indian customers require not very low-price but affordable product that best suits their need. Taking account of that, we are exploring the possibility of developing value-for-money products made especially for the Indian customer.